89 related articles for article (PubMed ID: 22314829)
1. Potential yoga modules for treatment of hematopoietic inhibition in HIV-1 infection.
Bhargav H; Raghuram N; Rao NH; Tekur P; Koka PS
J Stem Cells; 2010; 5(3):129-48. PubMed ID: 22314829
[TBL] [Abstract][Full Text] [Related]
2. Rescue of multi-lineage hematopoiesis during HIV-1 infection by human c-mpl gene transfer and reconstitution of CD34+ progenitor cells in vivo.
Zhang M; Poh TY; Louache F; Sundell IB; Yuan J; Evans S; Koka PS
J Stem Cells; 2009; 4(3):161-77. PubMed ID: 20232601
[TBL] [Abstract][Full Text] [Related]
3. Cytopenias in HIV infection: mechanisms and alleviation of hematopoietic inhibition.
Koka PS; Reddy ST
Curr HIV Res; 2004 Jul; 2(3):275-82. PubMed ID: 15279591
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a need-based integrated yoga program for cancer patients: a retrospective study.
Ram A; Raghuram N; Rao RM; Bhargav H; Koka PS; Tripathi S; Nelamangala RV; Kodaganur GS; Ramarao NH
J Stem Cells; 2012; 7(4):269-82. PubMed ID: 24196801
[TBL] [Abstract][Full Text] [Related]
5. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
[TBL] [Abstract][Full Text] [Related]
6. Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replication.
Costantini A; Giuliodoro S; Mancini S; Butini L; Regnery CM; Silvestri G; Greco F; Leoni P; Montroni M
AIDS; 2006 Aug; 20(13):1713-20. PubMed ID: 16931935
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 infection and hematologic picture.
Re MC; Zauli G; Furlini G; Giovannini M; La Placa M
Microbiologica; 1991 Apr; 14(2):165-76. PubMed ID: 1857267
[TBL] [Abstract][Full Text] [Related]
8. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
Pippi F
Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update.
Schnittman SM; Fauci AS
Adv Intern Med; 1994; 39():305-55. PubMed ID: 8140958
[TBL] [Abstract][Full Text] [Related]
10. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
[TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
Casoli C; Pilotti E; Bertazzoni U
AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell-based gene therapy against HIV infection: promises and caveats.
van Griensven J; De Clercq E; Debyser Z
AIDS Rev; 2005; 7(1):44-55. PubMed ID: 15875660
[TBL] [Abstract][Full Text] [Related]
13. Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.
Biswas P; Ferrarini M; Mantelli B; Fortis C; Poli G; Lazzarin A; Manfredi AA
Eur J Immunol; 2003 Jan; 33(1):252-63. PubMed ID: 12594854
[TBL] [Abstract][Full Text] [Related]
14. Change in CD4+ cell enumeration following aerobic exercise training in HIV-1 disease: possible mechanisms and practical applications.
LaPerriere A; Klimas N; Fletcher MA; Perry A; Ironson G; Perna F; Schneiderman N
Int J Sports Med; 1997 Mar; 18 Suppl 1():S56-61. PubMed ID: 9129263
[TBL] [Abstract][Full Text] [Related]
15. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
16. Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy.
Huang SS; Barbour JD; Deeks SG; Huang JS; Grant RM; Ng VL; McCune JM
Clin Infect Dis; 2000 Mar; 30(3):504-10. PubMed ID: 10722435
[TBL] [Abstract][Full Text] [Related]
17. Hematologic manifestations of infection with the human immunodeficiency virus.
Balea M
Rom J Intern Med; 1994; 32(2):87-118. PubMed ID: 7920333
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha.
Maciejewski JP; Weichold FF; Young NS
J Immunol; 1994 Nov; 153(9):4303-10. PubMed ID: 7523521
[TBL] [Abstract][Full Text] [Related]
19. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 negatively affects the survival/maturation of cord blood CD34(+) hematopoietic progenitor cells differentiated towards megakaryocytic lineage by HIV-1 gp120/CD4 membrane interaction.
Gibellini D; Vitone F; Buzzi M; Schiavone P; De Crignis E; Cicola R; Conte R; Ponti C; Re MC
J Cell Physiol; 2007 Feb; 210(2):315-24. PubMed ID: 17111363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
